Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Vaginal disorder
ADR ID BADD_A05890
ADR Hierarchy
21      Reproductive system and breast disorders
21.08      Vulvovaginal disorders (excl infections and inflammations)
21.08.01      Vulvovaginal disorders NEC
21.08.01.005      Vaginal disorder
Description Not Available
MedDRA Code 10061402
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Congenital or acquired abnormality of vagina complicating pregnancy, childbirth, or the puerperium | Congenital or acquired abnormality of vagina, antepartum condition or complication | Congenital or acquired abnormality of vagina, delivered, with mention of postpartum complication | Congenital or acquired abnormality of vagina, postpartum condition or complication | Congenital or acquired abnormality of vagina, unspecified as to episode of care in pregnancy | Congenital or acquired abnormality of vagina, with delivery | Noninflammatory disorders of vagina | Other specified noninflammatory disorders of vagina | Unspecified noninflammatory disorder of vagina | Vaginal disorder NOS | Vaginal disorder
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000404%
BADD_D00344Canagliflozin0.001532%
BADD_D00472Ciprofloxacin hydrochloride--
BADD_D00528Conjugated estrogens0.002074%
BADD_D00684Dinoprostone--
BADD_D00746Edoxaban tosylate--
BADD_D00821Estradiol0.000278%
BADD_D00912Fluconazole--
BADD_D01167Interferon alfa-2b--
BADD_D01250Lasofoxifene--
BADD_D01253Lenalidomide0.001158%
BADD_D01281Levonorgestrel0.007296%
BADD_D01336Macitentan0.000577%
BADD_D01933Ribavirin--
BADD_D01954Rivaroxaban0.000357%
The 1th Page    1    Total 1 Pages